CDC: New COVID Variant Estimated To Be No. 1 Strain In US
Authored by Jack Phillips via The Epoch Times (emphasis ours),
A new estimate from the U.S. Centers for Disease Control and Prevention shows that a COVID-19 variant that has been driving cases in China earlier this year is now the No. 1 strain in the United States.
A CDC estimate, updated on June 26, shows that between June 8 and June 21, the NB.1.8.1 variant now makes up 43 percent of COVID-19 cases in the United States and is ahead of the LP.8.1 variant.
Earlier this month, CDC data showed that NB.1.8.1 had 37 percent of cases and was No. 2 behind the LP.8.1 variant, which saw 38 percent of reported cases at the time. The new CDC estimate this week shows that LP.8.1 now makes up 31 percent of all cases.
The CDC says that wastewater levels show COVID-19 activity is “currently low” despite the NB.1.8.1 variant increase. Only Alaska is reporting “high” levels of the virus, while Hawaii, Nevada, Texas, Missouri, Mississippi, Florida, and Connecticut are seeing “moderate” levels, according to the CDC.
Last week, private data showed that states reporting the variant, which has been dubbed “Nimbus” in some media reports, include Arizona, California, Colorado, New Jersey, New York, Hawaii, Illinois, Maryland, Massachusetts, Ohio, Rhode Island, Utah, Vermont, Virginia, and Washington state as of June 19.
Chinese doctors earlier this month predicted a peak of nationwide COVID-19 cases in July, as the latest data released by Chinese health authorities show that variant NB 1.8.1 is still the main pathogen causing the rapid increase in COVID-19 infections in China.
An internal university research report at China’s Peking University stated that NB.1.8.1 may become the next dominant global strain, with symptoms including a sharp sore throat, fever, runny nose, vomiting, and diarrhea, according to previous Epoch Times reporting.
A worldwide rise in cases late last month is primarily in the Eastern Mediterranean, Southeast Asia, and Western Pacific regions, the World Health Organization said on May 28. The new variant had reached nearly 11 percent of sequenced samples reported globally in mid-May.
The WHO said some Western Pacific countries have reported increases in COVID cases and hospitalizations, but there’s nothing so far to suggest that the disease associated with the new variant is more severe than other variants.
In a statement to The Epoch Times in late May, a CDC spokesperson said the agency “is aware of reported cases of COVID-19 NB.1.8.1 in China and is in regular contact with international partners.”
Prior reports from The Epoch Times, citing Chinese doctors and outside health experts, have said that patients are reporting a sharp sore that’s been dubbed the “razor blade throat” or “razor throat.” Some media outlets, including The Associated Press and international media reports from the UK and India, have used the “razor throat” moniker to describe the NB.1.8.1 variant.
Due to the Chinese Communist Party’s history of covering up information and publishing unreliable data, including underreporting COVID-19 infections and related deaths since 2020, information provided by local doctors and health workers can offer valuable information for understanding the situation on the ground in the totalitarian country.
The Associated Press contributed to this report.
Tyler Durden Sun, 06/29/2025 – 22:10
Source: https://freedombunker.com/2025/06/29/cdc-new-covid-variant-estimated-to-be-no-1-strain-in-us/
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.
